Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

353 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
In vivo molecular imaging of chemokine receptor CXCR4 expression in patients with advanced multiple myeloma.
Philipp-Abbrederis K, Herrmann K, Knop S, Schottelius M, Eiber M, Lückerath K, Pietschmann E, Habringer S, Gerngroß C, Franke K, Rudelius M, Schirbel A, Lapa C, Schwamborn K, Steidle S, Hartmann E, Rosenwald A, Kropf S, Beer AJ, Peschel C, Einsele H, Buck AK, Schwaiger M, Götze K, Wester HJ, Keller U. Philipp-Abbrederis K, et al. Among authors: buck ak. EMBO Mol Med. 2015 Apr;7(4):477-87. doi: 10.15252/emmm.201404698. EMBO Mol Med. 2015. PMID: 25736399 Free PMC article.
Initial results in the assessment of multiple myeloma using 18F-FDG PET.
Schirrmeister H, Bommer M, Buck AK, Müller S, Messer P, Bunjes D, Döhner H, Bergmann L, Reske SN. Schirrmeister H, et al. Among authors: buck ak. Eur J Nucl Med Mol Imaging. 2002 Mar;29(3):361-6. doi: 10.1007/s00259-001-0711-3. Eur J Nucl Med Mol Imaging. 2002. PMID: 12002711 Clinical Trial.
Molecular imaging of proliferation in malignant lymphoma.
Buck AK, Bommer M, Stilgenbauer S, Juweid M, Glatting G, Schirrmeister H, Mattfeldt T, Tepsic D, Bunjes D, Mottaghy FM, Krause BJ, Neumaier B, Döhner H, Möller P, Reske SN. Buck AK, et al. Cancer Res. 2006 Nov 15;66(22):11055-61. doi: 10.1158/0008-5472.CAN-06-1955. Cancer Res. 2006. PMID: 17108145
[Nuclear medical diagnostics for liver tumors].
Buck AK, Stollfuss JC, Stahl A, Beer AJ, Meisetschläger G, Schwaiger M. Buck AK, et al. Internist (Berl). 2007 Jan;48(1):21-4, 26-9. doi: 10.1007/s00108-006-1769-6. Internist (Berl). 2007. PMID: 17195061 German.
Early metabolic response evaluation by fluorine-18 fluorodeoxyglucose positron emission tomography allows in vivo testing of chemosensitivity in gastric cancer: long-term results of a prospective study.
Ott K, Herrmann K, Lordick F, Wieder H, Weber WA, Becker K, Buck AK, Dobritz M, Fink U, Ulm K, Schuster T, Schwaiger M, Siewert JR, Krause BJ. Ott K, et al. Among authors: buck ak. Clin Cancer Res. 2008 Apr 1;14(7):2012-8. doi: 10.1158/1078-0432.CCR-07-0934. Clin Cancer Res. 2008. PMID: 18381939
Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine.
Buck AK, Herrmann K, Büschenfelde CM, Juweid ME, Bischoff M, Glatting G, Weirich G, Möller P, Wester HJ, Scheidhauer K, Dechow T, Peschel C, Schwaiger M, Reske SN. Buck AK, et al. Clin Cancer Res. 2008 May 15;14(10):2970-7. doi: 10.1158/1078-0432.CCR-07-4294. Epub 2008 Apr 29. Clin Cancer Res. 2008. PMID: 18445694 Clinical Trial.
SPECT/CT.
Buck AK, Nekolla S, Ziegler S, Beer A, Krause BJ, Herrmann K, Scheidhauer K, Wester HJ, Rummeny EJ, Schwaiger M, Drzezga A. Buck AK, et al. J Nucl Med. 2008 Aug;49(8):1305-19. doi: 10.2967/jnumed.107.050195. Epub 2008 Jul 16. J Nucl Med. 2008. PMID: 18632825 Free article.
353 results